Search

Your search keyword '"Moga, Shewki"' showing total 18 results
Start Over Author "Moga, Shewki"
18 results on '"Moga, Shewki"'

1. A smooth tubercle bacillus from Ethiopia phylogenetically close to the Mycobacterium tuberculosis complex

Author

Yenew, Bazezew, Ghodousi, Arash, Diriba, Getu, Tesfaye, Ephrem, Cabibbe, Andrea Maurizio, Amare, Misikir, Moga, Shewki, Alemu, Ayinalem, Dagne, Binyam, Sinshaw, Waganeh, Mollalign, Hilina, Meaza, Abyot, Tadesse, Mengistu, Gamtesa, Dinka Fikadu, Abebaw, Yeshiwork, Seid, Getachew, Zerihun, Betselot, Getu, Melak, Chiacchiaretta, Matteo, Gaudin, Cyril, Marceau, Michael, Didelot, Xavier, Tolera, Getachew, Abdella, Saro, Kebede, Abebaw, Getahun, Muluwork, Mehammed, Zemedu, Supply, Philip, and Cirillo, Daniela Maria

Published
2023
Full Text
View/download PDF

5. Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021

Author

Diriba, Getu, Alemu, Ayinalem, Tola, Habteyes Hailu, Eshetu, Kirubel, Yenew, Bazezew, Amare, Misikir, Dagne, Biniyam, Mollalign, Hilina, Sinshaw, Waganeh, Abebaw, Yeshiwork, Seid, Getachew, Tadesse, Mengistu, Zerihun, Betselot, Getu, Melak, Moga, Shewki, Meaza, Abyot, Gamtesa, Dinka Fekadu, Tefera, Zigba, Wondimu, Amanuel, Hailu, Michael, Buta, Bedo, Getahun, Muluwork, and Kebede, Abebaw

Published
2022
Full Text
View/download PDF

6. Pre-extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Ethiopia: a laboratory-based surveillance study

Author

Diriba, Getu, Alemu, Ayinalem, Tola, Habteyes Hailu, Yenew, Bazezew, Amare, Misikir, Eshetu, Kirubel, Sinshaw, Waganeh, Abebaw, Yeshiwork, Meaza, Abyot, Seid, Getachew, Moga, Shewki, Zerihun, Betselot, Getu, Melak, Dagne, Biniyam, Mollalign, Hilina, Tadesse, Mengistu, Buta, Bedo, Wordofa, Niguse, Alemu, Ephrem, Erresso, Ashenafi, Hailu, Michael, Tefera, Zigba, Wondimu, Amanuel, Belhu, Tegegn, Gamtesa, Dinka Fekadu, Getahun, Muluwork, Kebede, Abebaw, and Abdela, Saro

Published
2022
Full Text
View/download PDF

7. Acquired Bedaquiline and Fluoroquinolones Resistance during Treatment Follow-up in Oromia Region, North Shewa, Ethiopia

Author

Diriba, Getu, primary, Alemu, Ayinalem, additional, Ayano, Betselot Zerihun, additional, Yenew, Bazezew, additional, Hailu, Michael, additional, Buta, Bedo, additional, Wondimu, Amanuel, additional, Tefera, Zigba, additional, Ababu, Zerihun, additional, Ebisa, Yerosen, additional, Moga, Shewki, additional, and Tadesse, Gemechu, additional

Published
2024
Full Text
View/download PDF

8. Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis

Author

Alemu, Ayinalem, primary, Bitew, Zebenay Workneh, additional, Diriba, Getu, additional, Seid, Getachew, additional, Moga, Shewki, additional, Abdella, Saro, additional, Gashu, Emebet, additional, Eshetu, Kirubel, additional, Tollera, Getachew, additional, Dangisso, Mesay Hailu, additional, and Gumi, Balako, additional

Published
2023
Full Text
View/download PDF

10. Epidemiology of extensively drug-resistant tuberculosis among multidrug resistant tuberculosis patients: A systematic review and meta-analysis

Author

Diriba, Getu, primary, Alemu, Ayinalem, additional, Yenew, Bazezew, additional, Tola, Habteyes Hailu, additional, Gamtesa, Dinka Fikadu, additional, Mollalign, Hilina, additional, Eshetu, Kirubel, additional, Moga, Shewki, additional, Abdella, Saro, additional, Tollera, Getachew, additional, Kebede, Abebaw, additional, and Dangisso, Mesay Hailu, additional

Published
2023
Full Text
View/download PDF

12. Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia

Author

Diriba, Getu, primary, Kebede, Abebaw, additional, Tola, Habteyes Hailu, additional, Alemu, Ayinalem, additional, Yenew, Bazezew, additional, Moga, Shewki, additional, Addise, Desalegn, additional, Mohammed, Zemedu, additional, Getahun, Muluwork, additional, Fantahun, Mengistu, additional, Tadesse, Mengistu, additional, Dagne, Biniyam, additional, Amare, Misikir, additional, Assefa, Gebeyehu, additional, Abera, Dessie, additional, and Desta, Kassu, additional

Published
2022
Full Text
View/download PDF

13. Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia

Author

Meaza, Abyot, primary, Tesfaye, Ephrem, additional, Mohamed, Zemedu, additional, Zerihun, Betselot, additional, Seid, Getachew, additional, Eshetu, Kirubel, additional, Amare, Miskir, additional, Sinshaw, Waganeh, additional, Dagne, Biniyam, additional, Mollalign, Hilina, additional, Diriba, Getu, additional, Getu, Melak, additional, Yenew, Bazezew, additional, Tadesse, Mengistu, additional, Fikadu, Dinka, additional, Abebaw, Yeshiwork, additional, Moga, Shewki, additional, Kebede, Abebaw, additional, Tola, Habteyes Hailu, additional, Alemu, Ayinalem, additional, Getahun, Muluwork, additional, and Gumi, Balako, additional

Published
2021
Full Text
View/download PDF

14. Mycobacterial Lineages Associated with Drug Resistance in Patients with Extrapulmonary Tuberculosis in Addis Ababa, Ethiopia

Author

Diriba, Getu, primary, Kebede, Abebaw, additional, Tola, Habteyes Hailu, additional, Alemu, Ayinalem, additional, Yenew, Bazezew, additional, Moga, Shewki, additional, Addise, Desalegn, additional, Mohammed, Zemedu, additional, Getahun, Muluwork, additional, Fantahun, Mengistu, additional, Tadesse, Mengistu, additional, Dagne, Biniyam, additional, Amare, Misikir, additional, Assefa, Gebeyehu, additional, Abera, Dessie, additional, and Desta, Kassu, additional

Published
2021
Full Text
View/download PDF

15. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia

Author

Diriba, Getu, primary, Kebede, Abebaw, additional, Tola, Habteyes Hailu, additional, Yenew, Bazezew, additional, Moga, Shewki, additional, Addise, Desalegn, additional, Alemu, Ayinalem, additional, Mohammed, Zemedu, additional, Getahun, Muluwork, additional, Fantahun, Mengistu, additional, Tadesse, Mengistu, additional, Dagne, Biniyam, additional, Amare, Misikir, additional, Assefa, Gebeyehu, additional, Abera, Dessie, additional, and Desta, Kassu, additional

Published
2020
Full Text
View/download PDF

16. Performance of Mycobacterium Growth Indicator Tube BACTEC 960 with Lowenstein–Jensen method for diagnosis of Mycobacterium tuberculosis at Ethiopian National Tuberculosis Reference Laboratory, Addis Ababa, Ethiopia

Author

Diriba, Getu, primary, Kebede, Abebaw, additional, Yaregal, Zelalem, additional, Getahun, Muluwork, additional, Tadesse, Mengistu, additional, Meaza, Abyot, additional, Dagne, Zekarias, additional, Moga, Shewki, additional, Dilebo, Jibril, additional, Gudena, Kebebe, additional, Hassen, Mulu, additional, and Desta, Kassu, additional

Published
2017
Full Text
View/download PDF

17. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples

Author

Meaza, Abyot, primary, Kebede, Abebaw, additional, Yaregal, Zelalem, additional, Dagne, Zekarias, additional, Moga, Shewki, additional, Yenew, Bazezew, additional, Diriba, Getu, additional, Molalign, Helina, additional, Tadesse, Mengistu, additional, Adisse, Desalegn, additional, Getahun, Muluwork, additional, and Desta, Kassu, additional

Published
2017
Full Text
View/download PDF

18. Conventional and Molecular Methods for the Diagnosis of Smear Negative Pulmonary TB and Concordance of Empirical TB Diagnosis with Culture Assay.

Author

Getahun M, Dagne Z, Yaregal Z, Mariam AH, Moga S, Meaza A, Kebede A, and Feseha Y

Abstract

Background: Ethiopia is among high TB burden countries. The proportion of smear negative patients among pulmonary TB cases was 51%. Nevertheless, microscopy is still a primary tool for TB diagnosis. In the absence of sensitive diagnostic methods, clinicians often make the diagnosis of smear-negative pulmonary TB with information obtained through the clinical history, physical examination and chest X-ray. The treatment of smear negative TB patients with those criteria largely depends on the treating clinician. There is limited data on the utilization of clinical criteria commonly used to initiate TB treatment empirically when culture is used as the reference method. Beside this, there are a number of sensitive diagnostic methods that have a substantial contribution for the diagnosis of smear negative TB patients, but only few studies were conducted in Ethiopia to address this issue., Objective: To assess the contribution of conventional and molecular methods for smear-negative patients and describe the concordance rate of empiric TB treatment with culture assay., Methods: A cross-sectional study was designed on smear negative TB presumptive patients referred to St. Peter's TB Specialized Hospital from December 2014 to June 2015. Consecutive smear negative TB presumptive patients, aged greater or equal to 15 and willing to participate were included in the study. Socio-demographic and clinical data were collected using the data collection form designed for the study purpose. The data collection form was designed to capture patient demographic data, signs and symptoms, chest X-ray findings and empirical TB treatment initiations. Spot-Moring-spot sputum was collected using sterile falcon tubes for routine diagnostic purpose. Direct ZN examination was done on Spot-Moring-spot sputum at St. Peter's TB Specialized Hospital. The morning sputum was used for culture (LJ and MGIT), TB-LAMP, Xpert MTB/RIF assay and fluorescent microscopy examination. Data were captured and analyzed using SPSS., Results: This study enrolled 459 smear negative presumptive TB patients. Most (57%) of the study participants were female; with median age of 40 IQR (28-55) years. HIV test results were available for 41% of the study participants and the prevalence of HIV among the study participants was 30%. Three hundred eighty three cases were having both treatment and lab results. Forty six cases were treated empirically. The sensitivity and specificity of empiric TB treatment when compared to culture were 45.8% and 90% respectively. The overall culture positivity rate was 6.8% (30/439), of which 6.6% (26/391) was by MGIT and 5.3% (23/436) was by LJ method. Direct and concentrated fluorescent microscopy adds 0.9% and 1.3% detection rate compared to the direct ZN. The overall sensitivity and specificity of TB-LAMP was 61.5% (16/26) and 96.6% respectively. The overall sensitivity and specificity of Xpert MTB/RIF was 70.8% (17/24) and 97.2% respectively., Conclusion: TB-LAMP and Xpert MTB/RIFassaycan provide confirmatory results for at least two third of TB cases.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results